On September 24, 2018, the Blood Systems organization united under one shared name, Vitalant. Programs posted prior to that date may contain legacy branding.
This session will discuss the requirements of the FDA Guidance for Industry Assessing Donor Suitability and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection. It will also provide an overview of historical WNV data from 2011-2014, the AABB requirements for WNV testing, and outline the seasonal testing strategy and sample management that has been developed based on the above information.
Upon completion of the workshop, the participant will be able to:
Discuss the FDA Guidance and AABB requirements regarding NAT testing for WNV
Understand how historical West Nile Virus data plays a role in determining testing strategy
State the 2015 seasonal testing strategy
State the communication plan for reactive results
State sample management procedures during the monitoring season
Level of Instruction
Joan Dunn Williams, MT(ASCP); CHS(ABHI)
Technical Requirements and Assistance
To view the program material, you need a computer with a supported web browser and a dial-up or better internet connection. The supported operating systems and web browsers are: